BrainsWay Ltd. (BWAY) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
BrainsWay Ltd. (BWAY) Bundle
Enhance your investment strategies with the BrainsWay Ltd. (BWAY) DCF Calculator! Explore authentic BrainsWay financials, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of BrainsWay Ltd. (BWAY).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.1 | 22.1 | 29.7 | 27.2 | 31.8 | 34.8 | 38.2 | 41.9 | 45.9 | 50.3 |
| Revenue Growth, % | 0 | -4.52 | 34.46 | -8.36 | 16.96 | 9.63 | 9.63 | 9.63 | 9.63 | 9.63 |
| EBITDA | -6.6 | -3.5 | -4.7 | -11.5 | -2.3 | -7.6 | -8.4 | -9.2 | -10.0 | -11.0 |
| EBITDA, % | -28.5 | -15.7 | -15.76 | -42.15 | -7.27 | -21.87 | -21.87 | -21.87 | -21.87 | -21.87 |
| Depreciation | 2.8 | 1.6 | 1.7 | 1.5 | 1.3 | 2.4 | 2.7 | 2.9 | 3.2 | 3.5 |
| Depreciation, % | 12.1 | 7.34 | 5.68 | 5.64 | 4.21 | 6.99 | 6.99 | 6.99 | 6.99 | 6.99 |
| EBIT | -9.4 | -5.1 | -6.4 | -13.0 | -3.6 | -10.1 | -11.0 | -12.1 | -13.3 | -14.5 |
| EBIT, % | -40.6 | -23.04 | -21.44 | -47.79 | -11.48 | -28.87 | -28.87 | -28.87 | -28.87 | -28.87 |
| Total Cash | 21.9 | 17.2 | 57.3 | 47.9 | 46.0 | 32.9 | 36.1 | 39.6 | 43.4 | 47.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.5 | 5.6 | 6.3 | 4.8 | 3.8 | 7.0 | 7.7 | 8.4 | 9.2 | 10.1 |
| Account Receivables, % | 23.84 | 25.31 | 21.35 | 17.82 | 11.89 | 20.04 | 20.04 | 20.04 | 20.04 | 20.04 |
| Inventories | .3 | .4 | .2 | 3.8 | 3.7 | 2.1 | 2.3 | 2.5 | 2.7 | 3.0 |
| Inventories, % | 1.32 | 2 | 0.67438 | 14.12 | 11.69 | 5.96 | 5.96 | 5.96 | 5.96 | 5.96 |
| Accounts Payable | 1.3 | .8 | 1.1 | 1.1 | .8 | 1.4 | 1.5 | 1.6 | 1.8 | 2.0 |
| Accounts Payable, % | 5.71 | 3.54 | 3.72 | 4.11 | 2.38 | 3.89 | 3.89 | 3.89 | 3.89 | 3.89 |
| Capital Expenditure | -3.3 | -2.5 | -2.2 | 1.9 | -2.4 | -2.8 | -3.1 | -3.4 | -3.7 | -4.1 |
| Capital Expenditure, % | -14.33 | -11.2 | -7.55 | 7.12 | -7.51 | -8.12 | -8.12 | -8.12 | -8.12 | -8.12 |
| Tax Rate, % | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 |
| EBITAT | -9.8 | -5.3 | -6.4 | -13.3 | -3.9 | -10.1 | -11.0 | -12.1 | -13.3 | -14.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -14.8 | -6.9 | -7.1 | -12.0 | -4.1 | -11.4 | -12.2 | -13.4 | -14.7 | -16.1 |
| WACC, % | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -56.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -16 | |||||||||
| Terminal Value | -388 | |||||||||
| Present Terminal Value | -287 | |||||||||
| Enterprise Value | -343 | |||||||||
| Net Debt | -10 | |||||||||
| Equity Value | -333 | |||||||||
| Diluted Shares Outstanding, MM | 17 | |||||||||
| Equity Value Per Share | -20.08 |
What You Will Get
- Authentic BrainsWay Data: Preloaded financials – covering everything from revenue to EBIT – based on actual and projected figures.
- Comprehensive Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on BrainsWay’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and detailed forecasts.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Customizable Treatment Parameters: Adjust essential factors such as treatment duration, patient demographics, and expected outcomes.
- Instant Treatment Effectiveness Analysis: Quickly assesses the efficacy of various treatment protocols.
- Clinical-Grade Precision: Utilizes BrainsWay's real-world clinical data for accurate treatment evaluations.
- Effortless Outcome Comparisons: Evaluate different treatment scenarios and analyze results with ease.
- Efficiency Booster: Streamline the process without the need for complex treatment modeling from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review BrainsWay Ltd.'s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you adjust your assumptions.
- Step 5: Analyze the outputs and apply the results to your investment decisions.
Why Choose BrainsWay Ltd. (BWAY)?
- Save Time: Quickly access advanced neurostimulation solutions without the lengthy setup.
- Enhance Treatment Outcomes: Proven technology and methodologies lead to improved patient results.
- Fully Customizable: Adapt our services to meet the specific needs of your practice.
- User-Friendly Interface: Intuitive design ensures ease of use for both practitioners and patients.
- Backed by Research: Supported by extensive clinical studies and recognized by healthcare professionals.
Who Should Use BrainsWay Ltd. (BWAY)?
- Healthcare Investors: Develop comprehensive valuation models for investment analysis in the medical sector.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Deliver precise valuation insights for BrainsWay Ltd. (BWAY) to clients in the healthcare industry.
- Students and Educators: Utilize real-world data to enhance learning in financial modeling and healthcare economics.
- Medical Technology Enthusiasts: Gain insights into how companies like BrainsWay Ltd. (BWAY) are valued in the healthcare market.
What the Template Contains
- Pre-Filled Data: Includes BrainsWay Ltd.'s (BWAY) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze BrainsWay Ltd.'s (BWAY) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.